城市战中的四肢出血控制:铁剑战争回顾性分析
该研究为回顾性队列分析,纳入2023年10月27日至2024年11月30日期间住院的以色列军人战争伤员,数据来自院前创伤登记处和以色列国家创伤登记处,研究人群为院前阶段接受止血带治疗的住院士兵。主要结局为「不可转换止血带」,定义为存在血管损伤和/或需要早期截肢。2127例住院患者中589例(27.7%)院前使用止血带,106例(18.0%)诊断血管损伤,54例(9.2%)需早期截肢,144/589例(24.4%)存在妨碍院前止血带转换的损伤。合并失血性休克(校正OR=3.79,95%CI 2.44-5.92,p<0.001)和由ATLS提供者实施止血带(校正OR=1.55,95%CI 1.03-2.32,p=0.035)与不可转换止血带相关。作者认为战术环境中大多数止血带可能可以转换为其他出血控制方法,但失血性休克或ATLS提供者置入止血带时需特别谨慎,院前创伤培训应同时强调快速置入与识别并转换医学上不必要的止血带。
要点
- 2127例住院战争伤员中589例(27.7%)院前使用止血带,其中144/589例(24.4%)因血管损伤和/或需早期截肢而不可转换。
- 589例使用止血带者中106例(18.0%)诊断血管损伤,54例(9.2%)需早期截肢。
- 合并失血性休克者不可转换止血带的校正OR=3.79(95%CI 2.44-5.92,p<0.001)。
- 由ATLS提供者实施止血带者不可转换的校正OR=1.55(95%CI 1.03-2.32,p=0.035)。
- 作者认为战术环境中大多数止血带可能可以转换,但休克或ATLS提供者置入时需特别谨慎。
适用人群与场景
- 2023年10月27日至2024年11月30日期间住院的以色列军人战争伤员,且院前阶段接受止血带治疗。
- 数据来自院前创伤登记处和以色列国家创伤登记处。
诊断标准与关键阈值
- 不可转换止血带定义为存在血管损伤和/或需要早期截肢。
红旗征与不能漏的情况
- 合并失血性休克与不可转换止血带相关(校正OR=3.79,95%CI 2.44-5.92,p<0.001)。
- 由ATLS提供者实施止血带与不可转换止血带相关(校正OR=1.55,95%CI 1.03-2.32,p=0.035)。
研究设计与关键结果
- 研究类型为回顾性队列分析,样本量2127例住院患者,其中589例(27.7%)院前使用止血带。
- 589例使用止血带者中106例(18.0%)诊断血管损伤,54例(9.2%)需早期截肢。
- 144/589例(24.4%)存在妨碍院前止血带转换的损伤。
- 失血性休克与不可转换止血带独立相关:校正OR=3.79(95%CI 2.44-5.92,p<0.001)。
- ATLS提供者实施止血带与不可转换止血带独立相关:校正OR=1.55(95%CI 1.03-2.32,p=0.035)。
证据类型、等级与局限
- 证据类型:回顾性队列分析;证据等级:治疗/临床管理,Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为战术环境中大多数止血带可能可以转换为其他出血控制方法。
- 作者认为对表现为失血性休克或由ATLS提供者实施止血带的患者需特别谨慎。
- 作者建议院前创伤培训项目应同时强调快速置入止血带以及有效识别并转换医学上不必要的止血带,以减少肢体缺血和相关并发症。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Tourniquets are a life-saving intervention for controlling life-threatening extremity hemorrhage. However, prolonged tourniquet application can lead to significant morbidity. This study aimed to assess tourniquet usage among military personnel in modern urban warfare and evaluate the proportion of cases potentially suitable for tourniquet conversion.
METHODS: This was a retrospective cohort analysis of all Israeli military casualties hospitalized between October 27, 2023, and November 30, 2024, with war-related injuries during the Hamas-Israel War. Data were obtained from the prehospital trauma registry and the Israel National Trauma Registry. The study population comprised hospitalized soldiers who were treated with tourniquets during the prehospital phase. The primary outcome was "nonconvertible tourniquets," defined by the presence of vascular injury and/or the need for early limb amputation. A logistic regression was applied to identify injury-related factors independently associated with nonconvertible tourniquets.
RESULTS: Of 2,127 hospitalized patients, 589 (27.7%) were treated with prehospital tourniquets. Vascular injuries were diagnosed in 106 patients (18.0%), and 54 patients (9.2%) required early limb amputation. In total, 144 of 589 casualties (24.4%) had injuries that prevented prehospital tourniquet conversion. Factors associated with nonconvertible tourniquets included the presence of hemorrhagic shock (adjusted odds ratio=3.79, 95% confidence interval=2.44-5.92, p <0.001) and tourniquet application by an Advanced Trauma Life Support (ATLS) provider (adjusted odds ratio=1.55, 95% confidence interval=1.03-2.32, p =0.035).
CONCLUSIONS: Most tourniquets applied in tactical situations can potentially be converted to other hemorrhage control methods. However, particular caution is warranted in patients presenting with hemorrhagic shock or when tourniquets are applied by ATLS providers. Prehospital trauma training programs should emphasize not only the rapid application of tourniquets but also the effective identification and conversion of medically unnecessary tourniquets to minimize limb ischemia and associated complications. ( J Trauma Acute Care Surg . 2026;101: S36-S43. Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Surgery of Trauma.).
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Epstein D, Kvint O, Shlaifer A, et al. Extremity hemorrhage control in urban warfare: A retrospective analysis of the Swords of Iron War. J Trauma Acute Care Surg. 2026. PMID: 41860429. doi:10.1097/TA.0000000000004964
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。